Xiaolu Tao

A phase II, randomized, double‐blind, placebo‐controlled study evaluating the efficacy and safety of MDX‐1100, a fully human anti‐CXCL10 monoclonal antibody, in combination with methotrexate in patients with rheumatoid arthritis

Michael Yellin, I.A. Paliienko, Andra Bălănescu et al. · Arthritis & Rheumatism · 2011 · 197 citations

Medicine, Pharmacology, Pharmacotherapy +15

Anti-IP-10 antibody (BMS-936557) for ulcerative colitis: a phase II randomised study

Lloyd Mayer, William J. Sandborn, Yu.M. Stepanov et al. · Gut · 2013 · 192 citations · Full text

Life Sciences, Immunology, Pharmacology +16

Batoclimab vs Placebo for Generalized Myasthenia Gravis

Chong Yan, Yao-Xian Yue, Yuzhou Guan et al. · JAMA Neurology · 2024 · 41 citations · Full text

Life Sciences, Pharmacology, Pharmacotherapy +16

An improved LC–ESI–MS–MS method for simultaneous quantitation of rosiglitazone and N-desmethyl rosiglitazone in human plasma

Grace O’Maille, Sudhakar M. Pai, Xiaolu Tao et al. · Journal of Pharmaceutical and Biomedical Analysis · 2008 · 27 citations

Pharmacy, Pharmaceutical Analysis, Pharmacology +10

Effects of a Fixed-Dose Co-Formulation of Daclatasvir, Asunaprevir, and Beclabuvir on the Pharmacokinetics of a Cocktail of Cytochrome P450 and Drug Transporter Substrates in Healthy Subjects

Τushar Garimella, Xiaolu Tao, Karen Sims et al. · Drugs in R&D · 2017 · 25 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17